Evidence map›Paper›PMID 39639124›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2025

Hypertension awareness, treatment, control, and prognosis: insights from the sub-cohort of China PEACE million persons project.

Weida Qiu, Anping Cai, Shiping Wu, Yanchen Zhu, He Zheng, Zhiqiang Nie, Jiabin Wang, Yingqing Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weida QiuDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Anping CaiDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Shiping WuDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Yanchen ZhuDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
He ZhengDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Zhiqiang NieDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Jiabin WangDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Yingqing FengDepartment of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. fengyingqing@gdph.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is unclear whether and to what extent hypertension (HTN) awareness, treatment, and control affect prognosis in real-world settings. This study utilized data from the sub-cohort of the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project. A total of 102,358 adults aged 35-75 years were enrolled from Guangdong Province between January 2016 and December 2020. The primary outcomes were hospitalizations for major adverse cardiovascular events (MACEs) (a composite of myocardial infarction, coronary heart disease, stroke, heart failure, and cardiovascular mortality) and all-cause mortality. The secondary outcomes were the individual components of MACEs. Among the HTN patients, the proportions of HTN awareness and treatment were 58.6% and 48.7%, respectively. Only 22.0% and 7.9% of the population had their blood pressure (BP) controlled at <140/90 and <130/80 mmHg. Older age, female sex, higher socioeconomic status, elevated body mass index and waist circumference, as well as a history of DM, dyslipidemia, and cardiovascular disease, were associated with increased HTN awareness, treatment, and control. Current smokers and drinkers experienced lower chances of HTN care cascade. Hypertensive individuals with BP controlled at <130/80 mmHg faced similar risks of MACEs and mortality compared to normotensive individuals, while hypertensive subjects with uncontrolled BP or unawareness of HTN exhibited nearly double the risk of adverse cardiovascular outcomes. In conclusion, several factors were significantly associated with the performance of HTN awareness, treatment, and control. Hypertensive individuals with BP controlled at an optimal level shared a similar risk for MACEs and mortality compared to their normotensive counterparts.

Indexed as

Health Knowledge, Attitudes, PracticeHypertensionAdultAgedAntihypertensive AgentsBlood PressureChinaCohort StudiesFemaleHumansMaleMiddle AgedPrognosisAntihypertensive AgentsHypertension awarenessHypertension controlHypertension treatmentPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.